Toronto Square


ISSCR International Symposium
6-8 November 2019  |  Toronto, Canada

Program Highlights

From Stem Cell Biology to New Therapies presents a slate of world-renowned experts from academia and industry. Three days of scientific sessions will highlight the most current and promising clinical applications of stem cell therapies, including a panel that will discuss the regulatory challenges of translating discoveries made in the lab to the clinic.

Wednesday, 6 November

Pre-Meeting Session: Ethics and Policy Forum 

"From Germline Editing to Clinical Trial Design – the Ethical Issues and Practical Considerations of Moving Cell Therapies to the Clinic"
8:30-9:45 Session I: Ethical & Regulatory Considerations for Germline Genome Editing
Speaker: George Q. Daley, MD, PhD, Harvard University, USA
Speaker: Alta Charo, JD, University of Wisconsin Madison, USA  
Speaker: Leslie Thompson, PhD, University of California Irvine, USA

9:45-10:15 Coffee Break  

10:15-11:30 Session II: Ethical & Regulatory Challenges of Designing of Cell-Based Clinical Trials

Speaker: Charles Murry, MD, PhD, University of Washington, USA
Speaker: Kapil Bharti, PhD, National Institutes of Health, USA
Speaker: Matthew Majewski, BS, MBA, Charles River Associates

Symposium: From Stem Cell Biology to New Therapies
13:00-13:10 Welcoming Remarks
Robert Deans, PhD, BlueRock Therapeutics, USA
Nancy Witty, ISSCR, USA

13:10–14:00 Opening Keynote
Speaker: George Q. Daley, MD, PhD, Harvard University, USA

14:00–15:00 Diabetes
Session Chair: Cristina Nostro, PhD
Speaker: Felicia Pagliuca, PhD, Semma Therapeutics, USA
Speaker: Kevin D'Amour, PhD, Viacyte, USA

15:0015:30 Coffee Break
15:30–17:00 Cardiovascular Disease
Session Chair: Robert Deans, PhD  
Speaker: Michael Laflamme, MD, PhD, UHN, University of Toronto, Canada
Mauro Giacca, MD, PhD, ICGEB, Italy
Charles Murry, MD, PhD, University of Washington, USA

19:00 Welcome Reception

Thursday, 7 November

09:00–10:30 Neurodegenerative Diseases I
Session Chair: Lorenz Studer, MD
Speaker: Elena Cattaneo, PhD, University of Milan, Italy
Speaker: Leslie Thompson, PhD, University of California Irvine, USA
Speaker: Steven Goldman, MD, PhD, University of Rochester, USA
10:3011:00 Coffee Break
11:00–12:00 Neurodegenerative Diseases II
Session Chair: Sally Temple, PhD
Speaker: Hideyuki Okano, MD, PhD, Keio University, Japan
Speaker: Lorenz Studer, MD, Memorial Sloan Kettering Cancer Center, USA

12:00–13:30 Lunch

13:30–14:30 Vision Loss I
Session Chair: Sally Temple, PhD
Speaker: Kapil Bharti, PhD, National Institutes of Health, USA
Speaker: Rachael Pearson, PhD, University College London, UK

14:3015:00 Coffee Break

15:00–16:00 Vision Loss II & Diverse Applications
Session Chair: Jane Lebkowski, PhD
Speaker: Graziella Pellegrini, PhD, University of Modena and Reggio Emilia, Italy
Speaker: Erin Kimbrel, PhD, Astellas Pharma, USA

16:0018:00 Networking and Poster Reception

Friday, 8 November

09:00–10:30 Immunotherapy
Session Chair: Nissim Benvenisty, MD, PhD
Speaker: Dan Shoemaker, PhD, Fate Therapeautics, USA
Speaker: Harry Atkins, MD, FRCPC, Ottawa Hospital Research Institute, Canada
Speaker: Sjoukje van der Stegen, Memorial Sloan Kettering Cancer Center, USA
10:3011:00 Coffee Break
11:00–12:00 Escaping the Immune System
Session Chair: Gordon Keller, PhD
Speaker: Sonja Schrepfer, MD, PhD, University of California San Francisco, USA
Speaker: David Russell, MD, PhD, University of Washington, Universal Cells Inc., USA

12:00–13:30 Lunch

13:30–14:30 Panel Discussion: Regulatory Challenges
Moderator: Michael Laflamme, MD, PhD
Panelist: Doug Sipp, Riken, Japan
Panelist: Erin Kimbrel, PhD, Astellas Pharma, USA
Panelist: Joy Cavagnaro, PhD, Access BIO, USA

14:3015:00 Coffee Break

15:00–15:50 Closing Keynote
Jane Lebkowski, PhD, Regenerative Patch Technologies, USA

15:50–16:00 Final Remarks
Robert Deans, BlueRock Therapeutics, USA